Opko Health Inc (OPK): Frost’s Purchasing Binge Continues

0

Phillip A. G. Frost, CEO and Chairman at Opko Health Inc (NYSE:OPK) disclosed today the acquisition of 33,200 shares of common stock through twenty separate transactions, at unit prices ranging from $8.3 to $8.42, on November 5, 2014. Mr. Frost is for completing a great number of purchases throughout one day, confirming a yearly purchasing trend, and now indirectly owns a total of 15,490,546 shares and an additional 2,012,377 directly.

Kevin C. Tang’s Tang Capital Management is the largest shareholding institution (amongst those we track) at Opko Health Inc (NYSE:OPK) with 14 million shares, valued at an estimate $18.7 million, after reporting no changes at the end of the second filling period of 2014.

Opko Health Inc (NYSE:OPK) is a multi-national biopharmaceutical and diagnostics company developing a range of solutions to diagnose, treat and prevent various conditions, including molecular diagnostics tests, laboratory developed tests (LTDs), point-of-care tests and pharmaceuticals and vaccines.

Disclosure: The author, Jodor Jalit, holds no position in any stocks or funds mentioned.

Suggested Articles:

Largest Hedge Funds in Europe

Best Documentaries On Netflix

Share.